Search
Bio Rad Laboratories Inc
BIOAdd to Watchlist
379.570USD
+2.240+0.59%
Close 09-22 16:00（ET）
10.16BMarket Cap
63.13P/E TTM
Bio Rad Laboratories Inc (BIO) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Bio Rad Laboratories Inc in the past month.
Hold
0 Strong Buy
2 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
341.250USD-9.34%
BIO Analyst Recommendation Trends
In the current month, BIO has received 2 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. BIO average Analyst price target in the last month is 341.250.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
1
1
1
1
1
2
2
2
2
2
2
2
2
3
3
4
3
3
3
3
3
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
6
6
6
6
6
6
6
6
BIO Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, BIO EPS is projected to reach 2.231 in FY2026Q3, following reported EPS of 13.886 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.70
1.98
1.75
2.23
2.91
Actual
26.69
-19.55
13.89
--
--
Surprise
+888.39%
-1085.52%
+694.52%
--
--
FAQs
What is Bio Rad Laboratories Inc's expected revenue for the next quarter?
Bio Rad Laboratories Inc's expected revenue is 650.65M.
What is Bio Rad Laboratories Inc's price target?
Analysts forecast that Bio Rad Laboratories Inc's price target is USD 341.25, with the highest forecast at USD 390.00 and the lowest forecast at USD 315.00.
How have Bio Rad Laboratories IncBIO's recent earnings per share performed?
The market expectation was USD 13.89, while Bio Rad Laboratories IncBIO's earnings per share (EPS) for the previous quarter was USD -19.55. EPS for the next quarter is expected at USD 2.23.
What is the analyst rating for Bio Rad Laboratories Inc?
Based on the ratings of Bio Rad Laboratories Inc's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.